Mohamad Elbaz

Mohamad completed both his Bachelor degree in Pharmacy, as well as his Master degree in Pharmacology at the Helwan University in Cairo, Egypt. He then obtained his doctoral degree at the Ohio State University in Columbus, OH, USA. His thesis was investigating the role of cannabinoids and cannabinoid receptors as opportunities for breast cancer treatment. He then moved on to his first doctoral fellowship at the University of Chicago, IL, USA to study the role of various transcription factors in Triple Negative Breast Cancer (TNBC).

Currently, he is working in the Penn Lab as a Post-Doctoral Fellow, investigating the role of statins and dipyridamole and the effects these treatment options have on the mevalonate pathway in a breast cancer setting.